^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    OncoPrism™ Assay

    Company:
    Cofactor Genomics
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    OncoPrism™ is a new approach to characterizing the immune component of pre-treatment tumor tissue.
    Cancer:
    Squamous Cell Carcinoma of Head and Neck
    Gene:
    PD-L1 (Programmed death ligand 1)
    Method:
    Next-Generation Sequencing (NGS)